forthcoming articles

The following articles are a selection of those recently accepted for publication in Acta Crystallographica Section C: Structural Chemistry.

See also Forthcoming articles in all IUCr journals.

Accepted 6 September 2026

Crystal structure, inter­molecular inter­actions, Hirshfeld surface analysis, theoretical studies and biological evaluation of (E)-5-(benz­yloxy)-2-{[(2,5-di­meth­oxy­phen­yl)imino]­meth­yl}phenol, a new Schiff base

The title Schiff base compound was synthesized by the reaction of 4-(benz­yloxy)-2-hy­droxy­benzaldehyde and 2,4-di­meth­oxy­aniline in a 1:1 ratio. In the crystal, there are two independent mol­ecules in the asymmetric unit and both mol­ecules were refined as having a mixture of the imino–phenol and iminio–phenolate tautomeric forms. The compound exhibits significant inhibition properties.

Accepted 4 September 2026

On the SHELX, PLATON and IUCr/checkCIF crystal structure validation platform

With checkCIF the IUCr has created a unique platform for the validation and archival of the result of a small-mol­ecule crystal structure study.

Accepted 3 September 2026

Miro­gabalin, C12H19NO2, and miro­gabalin besylate, C12H20NO2+·C6H5O3S

The crystal structures of miro­gabalin and miro­gabalin besylate have been solved and refined using synchrotron powder X-ray diffraction data, and optimized using density functional theory techniques.

Accepted 1 September 2026

Synthesis of a phenazine radical anion com­plex: structural and spectroscopic analysis of spin delocalization

The crystallographic bond metrics of a 1:1 cocrystal containing a potassium–phenazine adduct and a phenazine-bridged homobimetallic zinc(II) com­plex indicate that the bimetallic zinc com­ponent is singly reduced. However, the solution-state electron paramagnetic resonance of this system indicates two distinct phenazine radical environments.

Accepted 20 August 2026

Synthesis, crystal structure, Hirshfeld surface analysis and halogen-involving inter­actions in a bromo/chloro-substituted Schiff base 1-(3-bromo-4,5-di­meth­oxy­phen­yl)-N-(2,4-di­chloro­phen­yl)methanimine